Abstract
PURPOSE: There is increasing enthusiasm with the use of anatomic segmentectomy as definitive surgical management for pathologic stage I NSCLC. Many reports focusing on the role of sublobar resection for stage I lung cancer have focused on pathologic stage, which may bias the perceived oncologic value of sublobar resection for clinical stage I disease. As surgical decision-making is based upon clinical stage, we compared the outcomes of patients undergoing wedge resection (n=130), anatomic segmentectomy (n=235), or lobectomy (n=728) for clinical stage I NSCLC.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
